Panacea Biotec gets warning letter from USFDA for Baddi plant

05 Oct 2020 Evaluate

Panacea Biotec has received warning letter from US Food and Drug Administration (USFDA) for violating current good manufacturing practice norms at its Baddi plant in Himachal Pradesh. This warning letter summarises significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals. Because methods, facilities, or controls for manufacturing, processing, packing, or holding do not conform to CGMP, company’s drug products are adulterated. The significant violations included company's failure to establish laboratory controls.

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

518.70 -19.40 (-3.61%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.85
Dr. Reddys Lab 1173.55
Cipla 1525.50
Lupin 2018.35
Zydus Lifesciences 859.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...